I love biomedical research. My blog is about shining a light on the people and events I encounter who inspire me because they do amazing things to advance medical research. I believe that good things happen when you bring together and connect really good people who care. I hope I can make some connections that will change the way research gets funded so we can bring more new ideas to life.
Time to Move Beyond the Ribbons?
This past week, I had the pleasure of meeting Massachusetts Senator Ed
Markey and Harvard Medical School Professor of Genetics, Dr. Fred Alt. They
were both in Washington, DC for the presentation of the 2015 NFCR Szent-Györgyi
Prize for Progress in Cancer Research, which was awarded to Dr. Alt and
keynoted by Sen. Markey.
The common theme I heard from both of these distinguished leaders was
captured in a Huffington Post article written by Sam Stein, who
attended the event.
Stein succinctly wrote that “U.S. Science has never been more imperiled”. He
noted that the lack of funding for basic scientific research not only prevents
new discoveries, but it also means that we are losing promising scientists
whose work can’t get funded.
10 years ago, nearly a third of qualified research was funded by
NIH.Now that number is only 14%
(actually even lower for oncology, near 9%).As Sen. Markey said, “sadly, support for scientific research in our
country is fragile”.And when I asked
Dr. Alt what his biggest concern was for the future of scientific discovery, he
lamented the prospects of losing good young people from the field entirely.
Since 2003, the
NIH budget has seen a 20% cut in purchasing power for new grants. It’s time
to move past the ribbons, and recognize that this is not a zero sum game.As a lung cancer survivor, I care a lot about
the need for research in this area.But
cancer research science has evolved to where we should not be looking just at
cancer type, or organ-specific research.Cancer is a genetic disease—that is, cancer is caused by changes
to genes that control the way our cells function, especially how they grow and
divide. These changes include mutations in the DNA that makes up our genes.
Genetic changes that increase cancer risk can be inherited from our parents, and
can also be acquired as the result of errors that occur as cells divide during
a person’s lifetime.
Awareness is great, but we need to get serious about cancer research
funding.No matter what ribbon you wear,
let’s realize that we truly are ALL in this together.30 years from now, if we have lost a
generation of promising scientists due to lack of resources, what progress will
we have made in the fight against cancer?
Have you ever met someone that just gives you a sense of confidence that anything is possible? I've met many researchers over the years and some of them just fill me with such hope that I feel that given the funding necessary to advance their ideas, a breakthrough would happen. I don't say this naively to suggest that it's just about money. Because I know that money doesn't solve all problems and in research there is no sure bet. But in medical research, often times good ideas stay in the minds of scientists due to lack of sufficient resources to do the experiments that could make huge advancements in understanding disease. And with some researchers you can just tell that they have ideas in their head that given the sufficient support there would be huge return. Researchers like Dr. Rudolf Jaenisch.
Ever since my lung cancer experience, I've been on a journey to try to be more grateful. To me living a life of gratitude means appreciating everything more and expressing that to people that I care about. I'm far from perfect at doing this, but I try my best to express my gratitude to others, to let them know that when they do things to help me, it means a lot to me. This gratitude journey started with my wife Missi and our three boys after my lobectomy and follow up treatment. It also has led me to find interesting people in my work life. People that go out of their way to volunteer to help me even when they are super busy with things in their own lives. People like Keith Spiro. I've never met anyone quite like him. What is amazing about him is that he's one of those guys that has so much going on behind the scenes you don't even realize how talented he is until he literally just shows you. He's the one who named me the Research Evangelist. And he's the o…
When speaking with people about cancer research over the years I often heard that a cure, or even advanced targeted treatments (especially for lung cancer) are just "pie in the sky" thinking. Of course, in my response now, I point to precision medicine approaches to treatment now available due to advances in genomic understanding about specific mutations in cancer. I heard the exact same thing a couple years ago when speaking with a parent of a child with Fragile X syndrome who asked me if using CRISPR to treat Fragile X was just "pie in the sky" - as in, is there a chance it could work, or is it just impossible? As an optimistic person, my answer was that given how rapidly technologies such as gene therapy and next generation sequencing are evolving, many things that seemed impossible are definitely not pie in the sky, even for complex disorders like Fragile X or diseases such as lung cancer.
The context of that conversation was an article she had read about how f…